BNP Paribas Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-377,329	Closed	-$16M	–	905
2023 Q4	$16M	Sell	377,329 -182,826	-33%	-$7.75M	0.04%	333
2023 Q3	$12.2M	Buy	560,155 +160,287	+40%	+$3.5M	0.04%	360
2023 Q2	$12.7M	Sell	399,868 -20,925	-5%	-$665K	0.04%	360
2023 Q1	$10.3M	Buy	+420,793	New	+$10.3M	0.04%	422